BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Saturday, April 20, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Nov. 10, 2010
View Archived Issues
CAT promoter polymorphism is linked to risk of vitiligo in Chinese individuals
Read More
Dutch scientists patent new modulators of glycoprotein hormone LH receptor
Read More
FDA sets PDUFA date for Endo Pharma's new formulation of long-acting oxymorphone hydrochloride
Read More
Curemark receives grant for development of CM-AT
Read More
Phase II data show benefit of pentoxifylline in nonalcoholic steatohepatitis
Read More
PLX-5622 reduces disease activity in a model of rheumatoid arthritis
Read More
In vivo data support potential of galantamine for treatment of obesity and related complications
Read More
Long-term Arikace therapy is well tolerated in patients with CF and P. aeruginosa infection
Read More
ECLIPSE trial compares Epanova with Lovaza
Read More
Nuvo Research presents topline phase II data on WF-10 in allergic rhinitis
Read More
Enrollment completed in Nabi Biopharma' second phase III NicVAX trial
Read More
FDA clears phase II trial of MultiStem in ulcerative colitis
Read More
TransTech Pharma and High Point Pharmaceuticals receive grants for development projects
Read More
Novel cannabinoid CB2 receptor ligands claimed by sanofi-aventis
Read More
Shire finalizes acquisition of Movetis
Read More
Infinity Pharma patents new fatty-acid amide hydrolase 1 inhibitors
Read More
Actelion Pharmaceuticals discloses novel antibacterial agents
Read More
Kyorin Pharma claims new muscarinic M3 receptor antagonists
Read More
Xoma receives grants to advance ongoing MAb development projects
Read More
MAP Pharmaceuticals reports results from Levadex QT trial
Read More
BioInvent receives FDA clearance for phase II trial of BI-204
Read More
Enanta Pharma discloses new HCV NS5 inhibitors
Read More
Apogee Biotech to begin phase I ABC-294640 development in several types of cancer
Read More
NeoPharm and Insys Therapeutics complete merger
Read More
Patient screening complete for phase III rhGAD65 trial in type 1 diabetes
Read More